ORGANIZATION AND BUSINESS (Details) $ in Millions	3 Months Ended
Mar. 31, 2023 USD ($) Product Facility
Organization and Business [Abstract]
Number of plasma collection facilities under approval and development \| Facility	10
Number of FDA-licensed plasma collection facilities \| Facility	8
Number of FDA approved product \| Product	3
Working capital \| $	$ 227.4
Cash and cash equivalents \| $	$ 69.2

Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Name:	us-gaap_CashEquivalentsAtCarryingValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant